THC BioMed International Ltd. Börsenlisting an der CSE
Wieder wagt ein kanadisches Marihuana-Unternehmen den Sprung an die Börse: Zum 29. April 2015 lässt sich THC BioMed Intl Ltd. (ISIN CA87243W1032, WKN. A14RM7, Kürzel: THC) an der Canadian Stock Exchange (CSE) listen. In Frankfurt wird der Handel ebenfalls möglich sein. THC BioMed, vormals THC medical Systemns Ltd. geht aus dem Mantel der Thelon Capital hervor. (Weitere Infos dazu gibts hier)
Process Steps for Becoming a Licensed Producer
Step 1: Preliminary Screening
When an application is received, it undergoes a preliminary screening for completeness. If an application is not complete, it will be returned. If an application is complete, it will be assigned an application number. The application number means that the application has completed the preliminary screening.
Step 2: Enhanced Screening
Once an application has been assigned an application number, it will be reviewed to ensure: that the location of the proposed site does not pose a risk to public health, safety and security; that the proposed security measures outlined in the application meet the requirements of the MMPR; and the proposed quality assurance person has the appropriate credentials to meet the good production requirements outlined in Division 4 of the MMPR. As a reminder, it is the responsibility of the applicant to ensure that they are in compliance with all applicable provincial, territorial, and municipal legislation, regulations and bylaws, including zoning restrictions.
Step 3: Security Clearance
Once the screening of an application is complete, the security clearance forms for key personnel will be sent for processing. The time required to conduct mandatory security checks varies with each application. Applicants should expect that security clearances will take several months at a minimum. Health Canada and the RCMP are not able to provide updates on the status of security checks. Applications will only advance to the review stage once the security clearances for the key personnel are completed. Please note that until such a time as Health Canada receives the results of the security checks, there will be no further communication from Health Canada.
Step 4: Review
Once all security clearances are obtained, an application will be thoroughly reviewed to validate the information provided. Given the extensive review process, applicants should anticipate communicating with the Office of Controlled Substances multiple times to provide clarifications on the application. Physical security plans will be reviewed and assessed in detail at this stage. Please note that applicants must meet a minimum of a level 7 to be considered for a licence. Information on the physical security directive can be found on the Health Canada website.
Step 5: Ready to build letter (if required by applicant)
Once the review of the application has been completed and it is confirmed that all requirements in the MMPR are met, applicants may request that Health Canada issue a "ready to build letter".
The "ready to build letter" is a notice informing the applicant that, if the licensed producer's site is built to the specifications outlined in the application that the physical security measures would meet the requirements of the MMPR. The "ready to build letter" is not a guarantee that a licence will be issued. The issuance of a licence under the MMPR is dependent upon the completion of a satisfactory inspection and is contingent on all key personnel identified in your application receiving the security clearance required under the MMPR.
Step 6: Prelicence inspection
Upon confirmation from the applicant that the site has been fully built and security measures are in place, a prelicence inspection will be scheduled. If any deficiencies are identified, they will be communicated to the applicant and must be addressed prior to a licence being issued.
Step 7: Licensing
Once it has been confirmed through the prelicence inspection that the applicant meets all the requirements of the MMPR, a licence will be issued. Health Canada has introduced a staged process for the issuance of licences. Applicants will first be issued a licence to produce only. This will enable Health Canada inspectors to confirm that the first batch of dried marijuana produced meets the good production practices and record keeping requirements outlined in the MMPR. It also allows Health Canada to verify the test results of the dried marijuana (e.g. for microbial and chemical contaminants) to ensure that the dried marijuana meets all quality control requirements before it is made available for sale.